Iberogast (Milk Thistle Fruit Extract, Bitter Candytuft Fresh Plant Extract, Matricaria Liquid Extract, Menthae)

Iberogast contains several herbal extracts that act together to relax gastrointestinal smooth muscle, suppress inflammatory mediators and stimulate mucosal protection. This multimodal action improves motility, reduces spasm and eases irritation of the digestive tract.

The dosage of Iberogast is determined by the prescribing healthcare professional based on the individual’s condition, age and response. Patients should follow the prescriber’s instructions and the product label for proper use.

Safety data for Iberogast in pregnancy and lactation are limited. It should be avoided unless the potential benefit justifies the potential risk, and the decision should be made by a qualified healthcare provider.

To request Iberogast, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike single‑active synthetic drugs, Iberogast combines multiple herbal extracts offering spasmolytic, anti‑inflammatory and pro‑kinetic effects in one formulation. It is an OTC option, whereas many alternatives require prescription and may have a narrower mechanism of action.

Iberogast should be stored at ambient temperature, below 25 °C, in its original container. Keep it away from moisture, direct sunlight and extreme heat to maintain product stability.

Iberogast is taken orally as a liquid suspension. The prescribed dose is usually measured with the provided dosing device and swallowed directly or mixed with a small amount of water, as instructed by the healthcare professional.

Serious adverse reactions, although rare, include allergic skin reactions, anaphylaxis and liver enzyme elevations. Patients should seek immediate medical attention if they experience rash, difficulty breathing, jaundice or any signs of severe hypersensitivity.

Iberogast should be avoided in individuals with known hypersensitivity to any of its herbal components, in patients with severe liver disease without close monitoring, and in pregnant or breastfeeding women unless a physician determines that the benefits outweigh the risks.